[
  {
    "ts": null,
    "headline": "Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board",
    "summary": "Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the appointment of Chris Cleary, former Senior Vice President of Corporate Development at Medtronic, as Chairman of its Board of Directors.",
    "url": "https://finnhub.io/api/news?id=bc180f4ee67681855d1f485d5f19b12beb5ead16a4a48451f877c4a0e12496d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764158400,
      "headline": "Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board",
      "id": 137611461,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the appointment of Chris Cleary, former Senior Vice President of Corporate Development at Medtronic, as Chairman of its Board of Directors.",
      "url": "https://finnhub.io/api/news?id=bc180f4ee67681855d1f485d5f19b12beb5ead16a4a48451f877c4a0e12496d3"
    }
  },
  {
    "ts": null,
    "headline": "Pediatric Interventional Cardiology Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue",
    "summary": "The Pediatric Interventional Cardiology Market is poised for significant growth, projected to rise from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, exhibiting a 6.68% CAGR. This expansion is driven by the increasing prevalence of congenital heart defects such as VSD, PDA, and ASD in children. The advent of advanced medical devices and the shift towards non-invasive treatments also contribute to market growth. The U.S. stands out as a key player due to rising infant cardiac abnormalitie",
    "url": "https://finnhub.io/api/news?id=0bd004e3b7793f9aa450455a0c4998cfeccc2f008ca22517f85a97c00639ab17",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764152760,
      "headline": "Pediatric Interventional Cardiology Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue",
      "id": 137611361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The Pediatric Interventional Cardiology Market is poised for significant growth, projected to rise from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, exhibiting a 6.68% CAGR. This expansion is driven by the increasing prevalence of congenital heart defects such as VSD, PDA, and ASD in children. The advent of advanced medical devices and the shift towards non-invasive treatments also contribute to market growth. The U.S. stands out as a key player due to rising infant cardiac abnormalitie",
      "url": "https://finnhub.io/api/news?id=0bd004e3b7793f9aa450455a0c4998cfeccc2f008ca22517f85a97c00639ab17"
    }
  },
  {
    "ts": null,
    "headline": "CMS covers cardiac ablation in ambulatory surgery centers",
    "summary": "Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.",
    "url": "https://finnhub.io/api/news?id=6d440735b566829ab45e64cd097b3e653a62f1a7d2d3619242969edc52973bdc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764151131,
      "headline": "CMS covers cardiac ablation in ambulatory surgery centers",
      "id": 137614465,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.",
      "url": "https://finnhub.io/api/news?id=6d440735b566829ab45e64cd097b3e653a62f1a7d2d3619242969edc52973bdc"
    }
  }
]